Could stem cells ease Parkinson's? new trial tests hope

NCT ID NCT04995081

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 2 trial tested whether infusions of stem cells (HB-adMSCs) from healthy donors could help people with Parkinson's disease. 60 participants received either the stem cells or a placebo (salt water) to see if the treatment improved movement and daily living. The study is complete, and results will show if this approach is safe and effective enough to pursue further.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs)

What this could lead to

If it works, this could point toward a new way to slow or improve motor symptoms in Parkinson's disease, potentially reducing disability.

What could go wrong

This is a small, early-phase (phase 2) study with only 60 people. Results may not apply to everyone, and stem cell treatments carry risks like immune reactions or unknown long-term effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hope Biosciences Stem Cell Research Foundation

    Sugar Land, Texas, 77478, United States